|
WO2010056726A1
|
|
Compositions and methods for treating diabetes
|
|
WO2009137074A1
|
|
Compositions and methods for treating diabetic ulcers
|
|
WO2009111037A2
|
|
Compositions and methods for treating nos-associated diseases
|
|
WO2009091582A1
|
|
PRODUCTION OF R-α-LIPOIC ACID BY FERMENTATION USING GENETICALLY ENGINEERED MICROORGANISMS
|
|
WO2009085223A1
|
|
Combination of metformin r-(+)-lipoate and antihyperglycemic agents for the treatment of diabetic hyperglycemia and diabetic complications
|
|
WO2009085198A2
|
|
Combination of metformin r-(+)-lipoate and antiobesity agents for the treatment of diabetic hyperglycemia and diabetic complications
|
|
TW200901959A
|
|
Combination of metformin R-(+) lipoate and antihyperlipidemic agents for the treatment of diabetic hyperglycemia and diabetic complications
|
|
WO2008112167A1
|
|
Combination of metformin r-(+) lipoate and antihypertensive agents for the treatment of diabetic hyperglycemia and diabetic complications
|
|
CN101522658A
|
|
Metformin R-(+) lipoate as an antidiabetic agent for control of diabetic hyperglycemia and diabetic complications
|
